Abstract
The technologies that constitute molecular diagnostics-first-generation
amplification, DNA probes, fluorescent in situ hybridization (FISH),
second-generation biochips and microfluidics, next-generation signal
detection, biosensors, and molecular labels-are influencing the discovery of
therapeutic molecules, the screening and diagnosis of patients, and the
optimization of drug therapy. In the past few years, this rapidly evolving
field has seen several fascinating developments. This TriMark Publications
report describes the specific market segment of the in vitro diagnostics
market known as molecular diagnostics and includes all of the generally
accepted clinical analytical activities in use today. It examines the
prevalent clinical-measurement devices, as well as their reagents and supplies
as utilized in hospitals, clinics, large reference laboratories and doctor' s
offices. Diagnostic tests marketed primarily as over-the-counter are generally
not included in this report, although there is inevitably some overlap. The
main objectives of this analysis are: 1) identifying viable technology drivers
through a comprehensive look at platform technologies for molecular
diagnostics, including probe-based nucleic acid assays, microarrays and
sequencing; 2) obtaining a complete understanding of the chief molecular
diagnostics tests-i.e., predictive, screening, prognostic, monitoring,
pharmacogenomic and theranostic-from their basic principles to their
applications; 3) discovering feasible market opportunities by identifying
high-growth applications in different clinical diagnostic areas and by
focusing on expanding markets, such as communicable diseases, cardiology and
oncology; and 4) focusing on global industry development through an in-depth
analysis of the major world markets for molecular diagnostics, including
growth forecasts.
By Purchasing This Report You Will Have:
- An improved understanding of the current state and future of the molecular
diagnostics market.
- The latest information on the leading companies engaged in research and
development and products in the pipeline.
- The leading perspective of recent imaging developments and revelations.
- Knowledge of the molecular diagnostics market as an area of growth,
research and investment.
This Report Will Cover the Following Molecular Diagnostics Technologies:
- Nucleic acid test applications.
- Blood testing and infectious diseases.
- Diagnostic testing using DNA.
- Cancer detection using PCR.
- Microbiology testing.
- Blood screening.
- SNPs in clinical diagnostics.
- Industrial testing and food diagnostics.
- Forensics market.
- Bioterrorism and molecular diagnostics.
- Cystic fibrosis testing.
- HLA sequencing-based typing kits
- Cytogenetic testing.
- Developments in biochips for clinical applications.
- Pharmacogenomics.
| 
View Cart
